1 |
王昱政,胡樱. 1992-2016年中国肾癌死亡趋势的年龄-时期-队列分析[J]. 中华流行病学杂志, 2021, 42(3):508-512.
|
2 |
He B, Zhao Z, Cai Q, et al. miRNA-based biomarkers, therapies, and resistance in cancer[J]. Int J Biol Sci, 2020, 16(14):2628-2647.
|
3 |
唐德平,邢梦洁,宋文涛,等. microRNA治疗在癌症及其他疾病中的研究进展[J].中国生物工程杂志, 2021, 41(11):64-73.
|
4 |
Yu Y, Liu L, Ma R, et al. MicroRNA-127 is aberrantly downregulated and acted as a functional tumor suppressor in human pancreatic cancer[J]. Tumour Biol, 2016, 37 (10):14249-14257.
|
5 |
Zhang J, Hou W, Chai M, et al. MicroRNA-127-3p inhibits proliferation and invasion by targeting SETD8 in human osteosarcoma cells[J]. Biochem Bioph Res Co, 2016, 469(4):1006-1011.
|
6 |
周丹丹,余娇娇,花芳,等.巨噬细胞迁移抑制因子,连接炎症和肿瘤的关键蛋白[J].药学学报, 2018, 53(11):1761-1769.
|
7 |
Mollaei H, Safaralizadeh R, Rostami Z. MicroRNA replacement therapy in cancer[J]. J Cell Physiol, 2019, 234(8):12369-12384.
|
8 |
赵军华,周志杰,崔吉冈,等. miR-138-5p靶向缺氧诱导因子对人肾癌细胞GRC-1生长、侵袭和迁移的影响[J].中国免疫学杂志, 2019, 35(5):564-569.
|
9 |
Wang K, Chen X, Zhan Y, et al. MiR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-W[J]. Tumour Biol, 2015, 36 (9):6875-6882.
|
10 |
张玉蓉,贾俊枝,徐国明,等. miR-127-3p靶向MAPK4对肝癌HepG2细胞株生物学特性的影响[J]. 中国免疫学杂志, 2020, 36(11):1330-1337.
|
11 |
Osipyan A, Chen D, Dekker FJ. Epigenetic regulation in macrophage migration inhibitory factor (MIF)-mediated signaling in cancer and inflammation[J]. Drug Discov Today, 2021, 26(7):1728-1734.
|
12 |
董辉,王晶,杨艳娟,等.过表达miR-451a通过靶向巨噬细胞迁移抑制因子(MIF)抑制HepG2细胞的增殖[J]. 细胞与分子免疫学杂志, 2018, 34(12):1091-1098.
|
13 |
王亚东,刘尚文,余绍龙,等. miR-127-3p在肾癌中的表达及生物学意义[J]. 广东医学, 2019, 40(12):1702-1705.
|
14 |
邹伟,张婷婷,曹玉珠,等.肿瘤转移前微环境形成机制的研究进展[J].中国药理学通报, 2018, 34(10):1348-1352.
|
15 |
Ismail MM, Morsi HK, Abdulateef NA, et al. Evaluation of prothrombin induced by vitamin K absence, macrophage migration inhibitory factor and Golgi protein-73 versus alpha fetoprotein for hepatocellular carcinoma diagnosis and surveillance[J]. Scand J Clin Lab Invest, 2017, 77(3) :175-183.
|
16 |
Balogh KN, Templeton DJ, Cross JV. Macrophage migration inhibitory factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses[J]. PLoS One, 2018, 13(6):e0197702. doi: 10.1371/journal.pone.0197702.
|